These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28090673)

  • 41. Exposure time-dependent bactericidal activities of amoxicillin against Actinobacillus pleuropneumoniae; an in vitro and In vivo pharmacodynamic model.
    Tanigawa M; Sawada T
    J Vet Med B Infect Dis Vet Public Health; 2003 Nov; 50(9):436-42. PubMed ID: 14633197
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sensitivity of A pleuropneumoniae and P multocida to ceftiofur.
    Hewett GR
    Vet Rec; 1994 Feb; 134(8):200. PubMed ID: 8171805
    [No Abstract]   [Full Text] [Related]  

  • 43. Pharmacokinetic/pharmacodynamic relationship of marbofloxacin against Pasteurella multocida in a tissue-cage model in yellow cattle.
    Shan Q; Wang J; Yang F; Ding H; Liang C; Lv Z; Li Z; Zeng Z
    J Vet Pharmacol Ther; 2014 Jun; 37(3):222-30. PubMed ID: 24033339
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antimicrobial susceptibility monitoring of respiratory tract pathogens isolated from diseased cattle and pigs across Europe: the VetPath study.
    de Jong A; Thomas V; Simjee S; Moyaert H; El Garch F; Maher K; Morrissey I; Butty P; Klein U; Marion H; Rigaut D; Vallé M
    Vet Microbiol; 2014 Aug; 172(1-2):202-15. PubMed ID: 24837878
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro and ex vivo antibacterial activity of levofloxacin against Pasteurella multocida and Escherichia coli isolated from rabbits (Oryctolagus cuniculus) - A preliminary study.
    Sitovs A; Skadins I; Purvina S; Bandere D
    J Vet Pharmacol Ther; 2023 Sep; 46(5):332-343. PubMed ID: 37060264
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetic and pharmacodynamic testing of marbofloxacin administered as a single injection for the treatment of bovine respiratory disease.
    Vallé M; Schneider M; Galland D; Giboin H; Woehrlé F
    J Vet Pharmacol Ther; 2012 Dec; 35(6):519-28. PubMed ID: 22126438
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Minimum inhibitory concentrations of tulathromycin against respiratory bacterial pathogens isolated from clinical cases in European cattle and swine and variability arising from changes in in vitro methodology.
    Godinho KS; Keane SG; Nanjiani IA; Benchaoui HA; Sunderland SJ; Jones MA; Weatherley AJ; Gootz TD; Rowan TG
    Vet Ther; 2005; 6(2):113-21. PubMed ID: 16094559
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of pigs experimentally infected with Mycoplasma hyopneumoniae, Pasteurella multocida, and Actinobacillus pleuropneumoniae with various antibiotics.
    Stipkovits L; Miller D; Glavits R; Fodor L; Burch D
    Can J Vet Res; 2001 Oct; 65(4):213-22. PubMed ID: 11768127
    [TBL] [Abstract][Full Text] [Related]  

  • 49.
    Xiao X; Lan W; Zhao Y; Li R; Liu Y; Liu J; Wang Z
    Front Microbiol; 2020; 11():616685. PubMed ID: 33505384
    [No Abstract]   [Full Text] [Related]  

  • 50. Water medication of a swine herd with amoxycillin.
    Agersø H; Friis C; Haugegaard J
    J Vet Pharmacol Ther; 1998 Jun; 21(3):199-202. PubMed ID: 9673960
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics/pharmacodynamics of marbofloxacin in a Pasteurella multocida serious murine lung infection model.
    Qu Y; Qiu Z; Cao C; Lu Y; Sun M; Liang C; Zeng Z
    BMC Vet Res; 2015 Dec; 11():294. PubMed ID: 26631082
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    Rattanapanadda P; Kuo HC; Vickroy TW; Sung CH; Rairat T; Lin TL; Yeh SY; Chou CC
    Front Microbiol; 2019; 10():2430. PubMed ID: 31749775
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro microbiological characterization of novel macrolide CP-163,505 for animal health specific use.
    Norcia LJ; Seibel SB; Kamicker BJ; Lemay MA; Lilley SC; Hecker SJ; Bergeron JM; Retsema JA; Hayashi SF
    J Antibiot (Tokyo); 1998 Feb; 51(2):136-44. PubMed ID: 9544934
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Integrated pharmacokinetic-Pharmacodynamic (PK/PD) model to evaluate the in vivo antimicrobial activity of Marbofloxacin against Pasteurella multocida in piglets.
    Zeng QL; Mei X; Su J; Li XH; Xiong WG; Lu Y; Zeng ZL
    BMC Vet Res; 2017 Jun; 13(1):178. PubMed ID: 28619095
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A large potentiation effect of serum on the in vitro potency of tulathromycin against Mannheimia haemolytica and Pasteurella multocida.
    Lees P; Illambas J; Potter TJ; Pelligand L; Rycroft A; Toutain PL
    J Vet Pharmacol Ther; 2017 Oct; 40(5):419-428. PubMed ID: 27891615
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacodynamics of oxytetracycline administered alone and in combination with carprofen in calves.
    Brentnall C; Cheng Z; McKellar QA; Lees P
    Vet Rec; 2012 Sep; 171(11):273. PubMed ID: 22843613
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of PK/PD Targets and Cutoff Values for Danofloxacin Against
    Zhou YF; Sun Z; Wang RL; Li JG; Niu CY; Li XA; Feng YY; Sun J; Liu YH; Liao XP
    Front Vet Sci; 2022; 9():811967. PubMed ID: 35187143
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Auxotrophic Actinobacillus pleurpneumoniae grows in multispecies biofilms without the need for nicotinamide-adenine dinucleotide (NAD) supplementation.
    Loera-Muro A; Jacques M; Avelar-González FJ; Labrie J; Tremblay YD; Oropeza-Navarro R; Guerrero-Barrera AL
    BMC Microbiol; 2016 Jun; 16(1):128. PubMed ID: 27349384
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Application of enrofloxacin and orbifloxacin disks approved in Japan for susceptibility testing of representative veterinary respiratory pathogens.
    Harada K; Usui M; Asai T
    J Vet Med Sci; 2014 Oct; 76(10):1427-30. PubMed ID: 25008965
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of enrofloxacin on porcine phagocytic function.
    Schoevers EJ; van Leengoed LA; Verheijden JH; Niewold TA
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2138-43. PubMed ID: 10471554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.